Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free
Close

Gilead Sciences Inc (GILD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
64.5500 -0.2200    -0.34%
23/09 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 3,524
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 64.5500 - 65.4900
Type:  Equity
Market:  Germany
ISIN:  US3755581036 
WKN:  885823
Gilead 64.5500 -0.2200 -0.34%

GILD Recent Sentiments

 
This page features our users' sentiments regarding the Gilead share. Assess users' predictions on whether they expect Gilead shares to be bearish or bullish.
Start Date Username Call Open Rate End Date Chg. %
Jun 02, 2022 Daniel Eder   58.5800 Jun 24, 2022 @ 58.8300 +0.43%
Mar 21, 2022 Gee Bo   53.6800 Apr 21, 2022 @ 58.5100 +9.00%
Nov 23, 2021 Andreas Rattay   62.5600 Dec 14, 2021 @ 61.8100 -1.20%
Nov 18, 2021 JUAN RIVERO   59.5200 Dec 10, 2021 @ 61.8000 +3.83%
Jun 30, 2021 Jiří Paikert   57.0000 Jul 23, 2021 @ 58.7300 +3.04%
Jun 07, 2021 Andreas Rattay   55.5000 Jul 02, 2021 @ 58.3800 +5.19%
May 10, 2021 Andreas Rattay   54.6800 Jun 04, 2021 @ 55.3700 +1.26%
May 04, 2021 Calzeitor AC   54.1200 May 28, 2021 @ 54.6000 +0.89%
Apr 06, 2021 JUAN RIVERO   56.0000 Apr 30, 2021 @ 52.2500 -6.70%
Mar 04, 2021 Jiří Paikert   52.1200 Mar 26, 2021 @ 55.1700 +5.85%
Jan 25, 2021 Michael Odenwald   54.8600 Feb 19, 2021 @ 53.4300 -2.61%
Jan 07, 2021 Leslie Fink   50.2500 Jan 24, 2021 @ 54.9100 +9.27%
Jan 04, 2021 Calzeitor AC   47.4650 Jan 29, 2021 @ 54.0500 +13.87%
Jan 04, 2021 JUAN RIVERO   47.5700 Jan 29, 2021 @ 54.0500 +13.62%
Dec 10, 2020 JUAN RIVERO   50.3000 Jan 01, 2021 @ 46.2500 -8.05%
Nov 23, 2020 Juno de Hauwere   50.4200 Dec 18, 2020 @ 48.0800 +4.64%
Nov 13, 2020 Alex Campoy   50.5000 Dec 04, 2020 @ 50.5000 0.00%
Nov 11, 2020 Ernesto Pailos   50.8600 Nov 13, 2020 @ 50.6100 +0.49%
Oct 29, 2020 André Simões   49.1000 Nov 20, 2020 @ 50.5200 +2.89%
Oct 23, 2020 Tony Mahomi   54.8100 Nov 13, 2020 @ 51.3300 -6.35%
Oct 20, 2020 JUAN RIVERO   51.2900 Nov 13, 2020 @ 51.3300 +0.08%
Oct 20, 2020 נתי גואטה   51.0300 Nov 13, 2020 @ 51.3300 +0.59%
Sep 25, 2020 Theo Michaux   53.3800 Oct 16, 2020 @ 53.2200 -0.30%
Sep 24, 2020 Thomas Fink   54.2200 Oct 16, 2020 @ 53.2200 +1.84%
Sep 23, 2020 Marco Ottlik   54.4900 Oct 16, 2020 @ 53.2200 -2.33%
Sep 07, 2020 vp pvv   55.7200 Oct 02, 2020 @ 53.6500 -3.72%
Aug 31, 2020 Werner Mueller   55.0600 Sep 25, 2020 @ 53.3900 -3.03%
Aug 31, 2020 Simon Hitman   54.8900 Sep 25, 2020 @ 53.3900 -2.73%
Aug 21, 2020 leonardo ceresa   56.1700 Sep 11, 2020 @ 55.1200 -1.87%
Aug 20, 2020 reghabi gholami...   55.4900 Sep 11, 2020 @ 55.1200 +0.67%
Aug 17, 2020 vp pvv   57.8200 Sep 07, 2020 @ 56.1800 -2.84%
Aug 14, 2020 Doru Eugen   57.7300 Sep 04, 2020 @ 56.1800 +2.68%
Aug 11, 2020 Jose Lm   58.2100 Aug 27, 2020 @ 55.2700 -5.05%
Aug 07, 2020 Ruski Gmnz   58.7300 Aug 28, 2020 @ 54.7600 -6.76%
Jul 17, 2020 Ze Fr   67.0500 Aug 07, 2020 @ 58.5900 -12.62%
Jul 16, 2020 Ze Fr   66.9200 Jul 17, 2020 @ 67.0500 +0.19%
Jul 15, 2020 Werner Mueller   67.2600 Aug 07, 2020 @ 58.5900 -12.89%
Jul 06, 2020 Der Uzo   68.6300 Jul 31, 2020 @ 58.7500 -14.40%
Jul 06, 2020 Tommy JM   70.3800 Jul 31, 2020 @ 58.7500 -16.52%
Jul 06, 2020 Jan le Roux   70.5000 Jul 31, 2020 @ 58.7500 -16.67%
Jul 03, 2020 Stefan Gebauer   70.3500 Jul 24, 2020 @ 63.8400 -9.25%
Jul 02, 2020 Simon Scheuermann   67.6800 Jul 24, 2020 @ 63.8400 -5.67%
Jul 02, 2020 Tina Nagel   68.3000 Jul 24, 2020 @ 63.8400 -6.53%
Jul 01, 2020 Javier CV   67.3400 Jul 02, 2020 @ 68.1600 +1.22%
Jun 30, 2020 Tam Tran   66.7000 Jul 24, 2020 @ 63.8400 +4.29%
Jun 29, 2020 Daniel Clerigo   67.1200 Jul 24, 2020 @ 63.8400 -4.89%
Jun 16, 2020 Rokefelix Diez   65.6800 Jul 10, 2020 @ 67.6500 +3.00%
Jun 15, 2020 Ana Maria Restrepo...   65.4100 Jul 10, 2020 @ 67.6500 +3.42%
Jun 12, 2020 Carmelo Sapienza   65.1400 Jul 03, 2020 @ 70.5000 +8.23%
Jun 08, 2020 Taner Kaplankiran   70.7400 Jul 03, 2020 @ 70.5000 -0.34%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GILD Comments

Write your thoughts about Gilead Sciences Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Oc Masai
Oc Masai Apr 27, 2021 7:54
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good job GILD. bullish move forward
Ashraf Elgendy
Ashraf Elgendy Mar 07, 2021 13:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Kite, a unit of Gilead Sciences (GILD),has announced that theFDA has granted approval for its T cell immunotherapy Yescarta (axicabtagene ciloleucel) for a certain category of adults...
RM RM
RM RM Mar 01, 2021 21:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Up Again
Ken Laing
Ken Laing Oct 23, 2020 18:43
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Time to load up before the big rise coming next week
Iggy Maldon
Iggy Maldon Jul 30, 2020 20:22
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Classic pump n’ dump. What a shambles
RM RM
RM RM May 28, 2020 22:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will reach above 95
Chili Daug
Chili Daug May 28, 2020 22:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
when? hahah
SAGAR AGARWAL
SAGAR AGARWAL May 15, 2020 14:52
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good time to accumulate.
Khizer Malik
Khizer Malik May 14, 2020 11:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Gilead will be supplying remdesivir to 127 countries starting next week! Also backed by big government organisations including donald trump. Good investmenr
Willy Chin
Willy Chin Apr 23, 2020 18:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
High chance to be trading above 90, good long stock
Viktor Veselý
Viktor Veselý Apr 12, 2020 7:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
By Deena Beasley(Reuters) - More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an experimental drug being developed by Gilead Sciences Inc., according to new data based on patient observation.The analysis, published on Friday by the New England Journal of Medicine, does not detail what other treatments the 61 hospitalized patients were given and data on eight of them were not included -- in one case because of a dosing error.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email